Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | CORT | STVN | ||
| Company | Valeant Pharmaceuticals Intl | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 24.15 | 83.41 | 21.00 | ||
| High | 24.43 | 83.70 | 21.10 | ||
| Low | 23.36 | 82.13 | 20.53 | ||
| Latest | 23.40 | 82.65 | 20.70 | ||
| Change | -0.83 | -0.94 | -0.25 | ||
| % Change | -3.43% | -1.12% | -1.19% | ||
| Volume | 6,569,300 | 342,899 | 124,430 | ||
| 20-Day Average Volume | 6,685,200 | 1,006,465 | 275,341 | ||
| Previous Close | 24.23 | 83.59 | 20.95 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 83.51 | 21.48 | ||
| 20-Day Raw Stochastic | 18.46% | 44.53% | 12.16% | ||
| 20-Day Relative Strength | 52.09 | 52.59 | 41.31 | ||
| Weighted Alpha | +35.20 | +36.79 | -9.64 | ||
| Today's Opinion | N/A | 88% Buy | 88% Sell | ||
| Previous Opinion | N/A | 100% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 80% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | +1.36% since 12/18/25 | +0.88% since 12/18/25 | ||
| Low | 23.02 on 07/09/18 | 80.38 on 12/23/25 | 20.25 on 12/19/25 | ||
| High | 24.43 on 07/13/18 | 85.34 on 12/19/25 | 21.10 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | +3.57% since 11/26/25 | -9.61% since 11/26/25 | ||
| Low | 22.56 on 06/28/18 | 77.55 on 12/01/25 | 20.25 on 12/19/25 | ||
| High | 27.25 on 06/14/18 | 89.00 on 12/15/25 | 23.95 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | -1.45% since 09/26/25 | -19.33% since 09/26/25 | ||
| Low | 16.76 on 04/16/18 | 67.00 on 11/05/25 | 20.25 on 12/19/25 | ||
| High | 27.79 on 06/13/18 | 91.00 on 10/08/25 | 27.99 on 10/24/25 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +11.19% since 06/26/25 | -17.50% since 06/26/25 | ||
| Low | 14.44 on 03/02/18 | 62.40 on 08/01/25 | 20.25 on 12/19/25 | ||
| High | 27.79 on 06/13/18 | 91.00 on 10/08/25 | 28.00 on 09/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 8,792,665 | 6,344,561 | ||
| Shares Outstanding, K | 348,710 | 105,188 | 302,843 | ||
| Annual Sales | 8,724,000,000 | 675,040,000 | 1,194,680,000 | ||
| Annual Net Income | 2,404,000,000 | 141,210,000 | 127,450,000 | ||
| Last Quarter Sales | 1,995,000,000 | 207,640,000 | 354,370,000 | ||
| Last Quarter Net Income | -2,693,000,000 | 19,670,000 | 42,160,000 | ||
| 60-Month Beta | -0.38 | 0.20 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | 0.16 on 11/04/25 | 0.16 on 11/06/25 | ||
| Latest Earnings Date | 08/14/18 | 02/25/26 | 03/05/26 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 93.17 | 35.32 | ||